Client testimonials

“I have been extremely satisfied with CBT’s services, having been a client since 2013. 

Through this partnership, we have had three successful pre-IND meetings with the FDA that have led to two IND filings, with a third in the works.  The recommendations provided by CBT were cost-effective and more importantly completely accepted by the Agency without question.  They are clearly an experienced group, provide timely responses, and have been a pleasure to work with.”


Jonathan Sorger, VP of Research, Intuitive Surgical

"CBT has been a key partner in our pre- and clinical development. They delivered our entire IND-enabling toxicology package (GLP toxicology in 2 species) on schedule and within budget. They developed extremely complex analytical assays for our lead compound and its metabolites and now support PK part of our clinical trials in Australia and USA. I was very impressed with how quick the studies were initiated, progressed  on schedule and always with high levels of quality control. In addition, along the way, we have received a lot of great advice on how to run our studies in a most efficient and cost-effective manner. CBT has become a part of our team and our go-to preclinical and analytical CRO." 


Ilya Rachman, MD, PhD, MBA

CEO, Immix Biopharma, Inc